These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 23417712)

  • 1. Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas.
    Fontebasso AM; Schwartzentruber J; Khuong-Quang DA; Liu XY; Sturm D; Korshunov A; Jones DT; Witt H; Kool M; Albrecht S; Fleming A; Hadjadj D; Busche S; Lepage P; Montpetit A; Staffa A; Gerges N; Zakrzewska M; Zakrzewski K; Liberski PP; Hauser P; Garami M; Klekner A; Bognar L; Zadeh G; Faury D; Pfister SM; Jabado N; Majewski J
    Acta Neuropathol; 2013 May; 125(5):659-69. PubMed ID: 23417712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of H3.3G34V mutation on genomic H3K36 and H3K27 methylation patterns in isogenic pediatric glioma cells.
    Huang TY; Piunti A; Qi J; Morgan M; Bartom E; Shilatifard A; Saratsis AM
    Acta Neuropathol Commun; 2020 Dec; 8(1):219. PubMed ID: 33287886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETD2 mutations in primary central nervous system tumors.
    Viaene AN; Santi M; Rosenbaum J; Li MM; Surrey LF; Nasrallah MP
    Acta Neuropathol Commun; 2018 Nov; 6(1):123. PubMed ID: 30419952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-driving H3G34V/R/D mutations block H3K36 methylation and H3K36me3-MutS╬▒ interaction.
    Fang J; Huang Y; Mao G; Yang S; Rennert G; Gu L; Li H; Li GM
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9598-9603. PubMed ID: 30181289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Grade Gemistocytic Morphology in H3 G34R-Mutant Gliomas and Concurrent K27M Mutation: Clinicopathologic Findings.
    Morris M; Driscoll M; Henson JW; Cobbs C; Jiang L; Gocke CD; Chen L; Rodriguez FJ
    J Neuropathol Exp Neurol; 2020 Oct; 79(10):1038-1043. PubMed ID: 32954438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies.
    Oliveira VF; De Sousa GR; Dos Santos AC; Saggioro FP; Machado HR; de Oliveira RS; Tone LG; Valera ET
    Childs Nerv Syst; 2021 Feb; 37(2):375-382. PubMed ID: 32766947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
    Ocasio JK; Budd KM; Roach JT; Andrews JM; Baker SJ
    Cancer Metastasis Rev; 2023 Jun; 42(2):367-388. PubMed ID: 37119408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts.
    Roux A; Pallud J; Saffroy R; Edjlali-Goujon M; Debily MA; Boddaert N; Sanson M; Puget S; Knafo S; Adam C; Faillot T; Cazals-Hatem D; Mandonnet E; Polivka M; Dorfm├╝ller G; Dauta A; Desplanques M; Gareton A; Pages M; Tauziede-Espariat A; Grill J; Bourdeaut F; Doz F; Dhermain F; Mokhtari K; Chretien F; Figarella-Branger D; Varlet P
    Neuro Oncol; 2020 Aug; 22(8):1190-1202. PubMed ID: 32025728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H3F3A K27M mutations in thalamic gliomas from young adult patients.
    Aihara K; Mukasa A; Gotoh K; Saito K; Nagae G; Tsuji S; Tatsuno K; Yamamoto S; Takayanagi S; Narita Y; Shibui S; Aburatani H; Saito N
    Neuro Oncol; 2014 Jan; 16(1):140-6. PubMed ID: 24285547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas.
    Gianno F; Antonelli M; Di Dio T; Minasi S; Donofrio V; Buccoliero AM; Gardiman MP; Pollo B; Diomedi Camassei F; Rossi S; Novello M; Giangaspero F; Arcella A; Gessi M; Buttarelli FR
    Am J Surg Pathol; 2021 Feb; 45(2):200-204. PubMed ID: 33428336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
    Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
    Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure/Function Analysis of Recurrent Mutations in SETD2 Protein Reveals a Critical and Conserved Role for a SET Domain Residue in Maintaining Protein Stability and Histone H3 Lys-36 Trimethylation.
    Hacker KE; Fahey CC; Shinsky SA; Chiang YJ; DiFiore JV; Jha DK; Vo AH; Shavit JA; Davis IJ; Strahl BD; Rathmell WK
    J Biol Chem; 2016 Sep; 291(40):21283-21295. PubMed ID: 27528607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.
    Salloum R; McConechy MK; Mikael LG; Fuller C; Drissi R; DeWire M; Nikbakht H; De Jay N; Yang X; Boue D; Chow LML; Finlay JL; Gayden T; Karamchandani J; Hummel TR; Olshefski R; Osorio DS; Stevenson C; Kleinman CL; Majewski J; Fouladi M; Jabado N
    Acta Neuropathol Commun; 2017 Oct; 5(1):78. PubMed ID: 29084603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors.
    Sangatsuda Y; Miura F; Araki H; Mizoguchi M; Hata N; Kuga D; Hatae R; Akagi Y; Amemiya T; Fujioka Y; Arai Y; Yoshida A; Shibata T; Yoshimoto K; Iihara K; Ito T
    Sci Rep; 2020 Sep; 10(1):16162. PubMed ID: 32999376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs.
    Jha P; Agrawal R; Pathak P; Kumar A; Purkait S; Mallik S; Suri V; Chand Sharma M; Gupta D; Suri A; Sharma BS; Julka PK; Kulshreshtha R; Sarkar C
    Int J Cancer; 2015 Nov; 137(10):2343-53. PubMed ID: 25994230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and clinicopathological features of H3.3 G34-mutant high-grade gliomas: a retrospective study of 411 consecutive glioma cases in a single institution.
    Yoshimoto K; Hatae R; Sangatsuda Y; Suzuki SO; Hata N; Akagi Y; Kuga D; Hideki M; Yamashita K; Togao O; Hiwatashi A; Iwaki T; Mizoguchi M; Iihara K
    Brain Tumor Pathol; 2017 Jul; 34(3):103-112. PubMed ID: 28447171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.
    Solomon DA; Wood MD; Tihan T; Bollen AW; Gupta N; Phillips JJ; Perry A
    Brain Pathol; 2016 Sep; 26(5):569-80. PubMed ID: 26517431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Epigenetic Pathways in the Treatment of Pediatric Diffuse (High Grade) Gliomas.
    Vanan MI; Underhill DA; Eisenstat DD
    Neurotherapeutics; 2017 Apr; 14(2):274-283. PubMed ID: 28233220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breast.
    Tsang JY; Lai ST; Ni YB; Shao Y; Poon IK; Kwan JS; Chow C; Shea KH; Tse GM
    Breast Cancer Res Treat; 2021 Jun; 187(2):339-347. PubMed ID: 33844099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
    Jain SU; Khazaei S; Marchione DM; Lundgren SM; Wang X; Weinberg DN; Deshmukh S; Juretic N; Lu C; Allis CD; Garcia BA; Jabado N; Lewis PW
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27354-27364. PubMed ID: 33067396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.